Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Ossium Health, Inc.
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University